… requirements and new clinical trial designs. And on … faster than the marketed treatment and, according to Biogen … pulmonary arterial hypertension drug developer Respira Therapeutics, the … previously failed studies in epilepsy and osteoarthritis-related …

… diagnosis and treatment.7 Current treatment primarily consists … psychology, skin therapy, program development management, and patient advocacy. … -management program on medication adherence of epileptic … support to enhance adult epilepsy self-management: an …

… multiple sclerosis, Alzheimer’s disease, epilepsy, and stroke. Microbial interventions, such … FXS patients, unreported in normal development, highlights disease-specific metabolic … of intestinal microbiota and probiotics treatment in children with autism …

… Develop hypersomnia Understanding by Evaluating low-sodium oxybate Treatment) trial, showing treatment … Administration (FDA) for the treatment of cataplexy … III drugs, substances, or chemicals as drugs … epilepsy, and a growing portfolio of cancer treatments …

… are issued. Currently, four Korean-developed drugs with notable sales in the … ’s neutropenia treatment Rolontis (marketed as Rolvedon), SK biopharmaceuticals' epilepsy drug … the latest announcement by securing FDA approval for a local facility …

… how Magdalen had developed post traumatic epilepsy years after … that for some people, medication exacerbates the situation.’ … had been prescribed several drugs for the condition but … and tourist attraction. His treatments included ‘psychic surgeries’ during …

… dedicated to drug discovery, clinical development, and commercialization of life-changing … non-opioid treatments for pain. Webinar: Developing Novel Non-Opioid Treatments for … in Phase 3 clinical trials for the treatment of epilepsy, major depressive disorder …

… In April 2024, the FDA granted orphan drug designation to … , single-arm phase 2 trial (NCT05795920) revealed that 20 … , or immunotherapy for the treatment of pancreatic cancer, had … a history of uncontrolled epilepsy, central nervous system disease …

… necessary to develop new methods or drugs for the treatment of … pulmonary fibrosis, chronic obstructive pneumonia, epilepsy, tumors, heart failure, and … the Phase III clinical trial stage).13 I-BET151 … Z. Recent FDA approvals in the treatment of graft-versus …

… rare and severe form of developmental epileptic encephalopathy in children, often … potential as a treatment option for all individuals with epilepsy. Subjects with … recognition you deserve! The Clinical Trials Arena Excellence Awards celebrate innovation …